Login
Toggle navigation
Videos
Categories
Trending
In the latest Shot Callers episode, Mark Mastalir, Co-CEO of Halo Neuroscience, discusses insights on the company; subscribe to the FOS Daily newsletter for updates.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Parker · CEO at Halo Security
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Northland Power Inc is moderated by Melanie Noronha, senior editor, amidst a keynote address by NVIDIA CEO Jensen Huang at the 2024 SIEPR Economic Summit.
00:10:00
The benefits for startups to raise funds from celebrity investors such as American actor|Keisuke Honda,Co-Founder,Dreamers VC
00:10:00
Economic and Market Outlook: Our View | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management
00:00:00
Mike Timoney: Introduction to Smiles Inclusive - a new model for dental partnerships - Mike Timiney, CEO, Smiles Inclusive Ltd
00:10:00
From Romania to NASA to Silicon Valley|Oana Olteanu,Partner,SignalFire
00:10:00
"High Yield Bond Market Outlook for the Second Half of 2024: Key Insights from AXA’s Fund Manager and BBLAM's Navarat Jeamkijrung"
00:10:00
CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public.
00:10:00
Singular Vision for Success: The Journey of Unifying Marketing Solutions|CEO,Zeta Global Holdings Corp
00:10:00
Kane Brenan Analyzes 2018 Investment Outlook and Its Implications for Major Asset Classes in Insightful Presentation
00:10:00
First Mining Gold CEO Dan Wilton Presents Strategic Initiatives and Growth Prospects
00:10:00
Exploring the Intersection of Technology and Wellness: A Conversation with Irfan Sadiq, Founder of Blue Gem Hemp
00:10:00
Methodology & Procedure Amper Technologies | Akshat Thirani, CEO, Amper SAAPR:MUN